Dynamic contrast‐enhanced MRI for assessing the disease activity of multiple myeloma: A comparative study with histology and clinical markers
Open Access
- 21 June 2005
- journal article
- research article
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 22 (1) , 154-162
- https://doi.org/10.1002/jmri.20349
Abstract
Purpose: To examine whether parameters of dynamic, contrast‐enhanced MRI (DCE MRI) reflect the degree of infiltration and vessel density in corresponding bone marrow biopsy specimens.Materials and Methods: The pelvis of 24 patients with multiple myeloma (MM) was examined using contrast‐enhanced DCE MRI. Biopsy was obtained from the spina iliaca posterior superior. Using a two‐compartment model (assuming one intravascular and one interstitial compartment), the parameters amplitude (A, the maximum, relative signal increase over baseline) and the exchange rate constant (kep, describing the redistribution of contrast agent from the interstitial into the intravascular compartment) in the biopsied region were calculated and compared with the histological and clinical data.Results: DCE MRI parameters were significantly higher in lesions with marked infiltration than with mild or no infiltration (P < 0.05). The amplitude normalized to that in the iliac artery (An), but not kep, was higher in lesions with high vessel‐density at histology (P = 0.01). Higher kep levels were found in presence of increased serum immunoglobulins.Conclusion: Increased contrast uptake in the bone marrow of MM patients indicates at least moderate tumor involvement. Furthermore, the contrast enhancement correlates with vessel‐density and serum markers of disease activity. J. Magn. Reson. Imaging 2005;22:154–162.Keywords
This publication has 25 references indexed in Scilit:
- Increased expression of vascular endothelial growth factor in bone marrow of multiple myeloma patientsEuropean Journal of Internal Medicine, 2003
- Elevated serum concentration of hepatocyte growth factor in patients with multiple myeloma: Correlation with markers of disease activityAmerican Journal of Hematology, 2003
- The clinical and prognostic significance of erythrocyte sedimentation rate (ESR), serum interleukin-6 (IL-6) and acute phase protein levels in multiple myelomaClinical and Laboratory Haematology, 2003
- Dynamic T1‐weighted monitoring of vascularization in human carcinoma heterotransplants by magnetic resonance imagingInternational Journal of Cancer, 2003
- Magnetic resonance imaging as a supplement for the clinical staging system of Durie and Salmon?Cancer, 2002
- Increased bone marrow microvessel density in newly diagnosed multiple myeloma carries a poor prognosisSeminars in Oncology, 2001
- Antitumor Activity of Thalidomide in Refractory Multiple MyelomaNew England Journal of Medicine, 1999
- Modeling tracer kinetics in dynamic Gd‐DTPA MR imagingJournal of Magnetic Resonance Imaging, 1997
- Pharmacokinetic Mapping of the Breast: A New Method for Dynamic MR MammographyMagnetic Resonance in Medicine, 1995
- Plastic embedding in routine histology I: Preparation of semi‐thin sections of undecalcified marrow coresHistopathology, 1985